Comment diagnostique-t-on une dermatoses vasculaire ?

Le diagnostic repose sur l'examen clinique et parfois des biopsies cutanées.

Quels tests sont utilisés pour évaluer les dermatoses vasculaires ?

Des tests comme l'échographie Doppler et l'angiographie peuvent être utilisés.

Les dermatoses vasculaires nécessitent-elles des examens sanguins ?

Des examens sanguins peuvent être réalisés pour évaluer des troubles sous-jacents.

Quels signes cliniques indiquent une dermatoses vasculaire ?

Des rougeurs, des ecchymoses ou des lésions vasculaires visibles peuvent indiquer une affection.

Peut-on confondre les dermatoses vasculaires avec d'autres maladies ?

Oui, elles peuvent être confondues avec des maladies comme le psoriasis ou l'eczéma.

Quels sont les symptômes courants des dermatoses vasculaires ?

Les symptômes incluent des rougeurs, des démangeaisons, et des lésions cutanées.

Les dermatoses vasculaires provoquent-elles des douleurs ?

Elles peuvent provoquer des douleurs, surtout si les lésions sont enflammées.

Les dermatoses vasculaires peuvent-elles causer des saignements ?

Oui, certaines peuvent entraîner des saignements, notamment les télangiectasies.

Y a-t-il des symptômes systémiques associés ?

Des symptômes comme la fièvre ou la fatigue peuvent survenir dans certains cas.

Les démangeaisons sont-elles fréquentes ?

Oui, les démangeaisons sont un symptôme fréquent des dermatoses vasculaires.

Comment prévenir les dermatoses vasculaires ?

Éviter les facteurs de risque comme l'exposition au soleil et le tabagisme peut aider.

L'hydratation de la peau est-elle importante ?

Oui, maintenir la peau hydratée peut réduire le risque d'irritation et de lésions.

Les vêtements peuvent-ils aider à prévenir ces affections ?

Oui, porter des vêtements protecteurs peut réduire l'exposition aux irritants.

Faut-il éviter certains aliments ?

Certaines personnes peuvent bénéficier d'un régime anti-inflammatoire pour réduire les symptômes.

Le stress influence-t-il les dermatoses vasculaires ?

Oui, le stress peut aggraver les symptômes, donc des techniques de gestion du stress sont utiles.

Quels traitements sont disponibles pour les dermatoses vasculaires ?

Les traitements incluent des crèmes topiques, des lasers et parfois des médicaments oraux.

Les corticostéroïdes sont-ils efficaces ?

Oui, les corticostéroïdes peuvent réduire l'inflammation et les symptômes cutanés.

Quand faut-il envisager une intervention chirurgicale ?

Une intervention chirurgicale est envisagée pour les cas graves ou réfractaires aux traitements.

Les traitements naturels sont-ils recommandés ?

Certains traitements naturels peuvent aider, mais il est important de consulter un médecin.

Les lasers sont-ils efficaces pour traiter ces affections ?

Oui, les lasers peuvent réduire l'apparence des lésions vasculaires et améliorer l'esthétique.

Quelles complications peuvent survenir ?

Des complications comme des infections ou des cicatrices peuvent survenir si non traitées.

Les dermatoses vasculaires peuvent-elles affecter la qualité de vie ?

Oui, elles peuvent entraîner des problèmes psychologiques et affecter l'estime de soi.

Y a-t-il un risque de cancer associé ?

Certaines dermatoses vasculaires peuvent avoir un risque accru de cancer cutané.

Les complications sont-elles fréquentes ?

Les complications ne sont pas fréquentes mais peuvent survenir dans des cas graves.

Comment gérer les complications ?

La gestion des complications nécessite souvent une approche multidisciplinaire et un suivi régulier.

Quels sont les principaux facteurs de risque ?

Les facteurs incluent l'âge, le sexe féminin, et des antécédents familiaux de dermatoses.

Le tabagisme est-il un facteur de risque ?

Oui, le tabagisme peut aggraver les dermatoses vasculaires et augmenter les symptômes.

L'exposition au soleil influence-t-elle ces affections ?

Oui, l'exposition excessive au soleil peut aggraver les dermatoses vasculaires.

Le stress est-il un facteur de risque ?

Oui, le stress peut exacerber les symptômes et augmenter le risque de dermatoses.

Les maladies chroniques augmentent-elles le risque ?

Certaines maladies chroniques, comme le diabète, peuvent augmenter le risque de dermatoses.

Dermatoses vasculaires - Informations médicales vérifiées

A case-control study of infections caused by

2022

DOI: 10.3389/fcimb.2022.867347 PMID: 35967868

Infections caused by antimicrobial-resistant bacteria are a significant cause of death worldwide, and carbapenemase-producing bacteria are the principal agents. New Delhi metallo-beta-lactamase-1 prod... A retrospective case-control study with patients hospitalized from January 2012 to February 2018 at the Hospital Civil de Guadalajara "Fray Antonio Alcalde" was designed. During this period, 139 patie... One hundred and thirty-nine case patients with a KP-NDM-1 isolate and 486 control patients were analyzed. In the case group, acute renal failure was a significant comorbidity, hospitalization days wer... In this study, the previous use of antibiotics, the use of a urinary catheter, the use of a central venous catheter, the use of mechanical ventilation, and ICU stay were shown to be predictors of infe...

Anti-Bacterial Agents Case-Control Studies Humans Klebsiella Infections Klebsiella pneumoniae +2 autres

Errors in Surgery: A Case Control Study.

01 11 2022

DOI: 10.1097/SLA.0000000000005664 PMID: 35946794

While errors can harm patients they remain poorly studied. This study characterized errors in the care of surgical patients and examined the association of errors with morbidity and mortality.... Errors have been reported to cause <10% or >60% of adverse events. Such discordant results underscore the need for further exploration of the relationship between error and adverse events.... Patients with operations performed at a single institution and abstracted into the American College of Surgeons National Surgical Quality Improvement Program from January 1, 2018, to December 31, 2018... Of 1899 patients, 170 were defined as cases who experienced a morbidity or mortality. The majority of cases (n=93; 55%) had at least 1 error; of the 329 matched control patients, 112 had at least 1 er... Errors in surgical care were associated with postoperative morbidity. Reducing errors requires measurement of errors....

Case-Control Studies Humans Morbidity Odds Ratio Postoperative Complications +2 autres

Iron status in women with infertility and controls: a case-control study.

2023

DOI: 10.3389/fendo.2023.1173100 PMID: 37361544

Iron deficiency is a common problem in subfertile women. The influence of iron status on unexplained infertility is unknown.... In a case-control study, 36 women with unexplained infertility and 36 healthy non-infertile controls were included. Parameters of iron status including serum ferritin and a serum ferritin <30 µg/dL se... Women with unexplained infertility demonstrated a lower transferrin saturation (median 17.3%, IQR 12.7-25.2 versus 23.9%, IQR 15.4-31.6;... Ferritin levels <30µg/L were associated with unexplained infertility and might be screened in the future. Further studies with a focus on iron deficiency and iron treatment on women with unexplained i...

Humans Female Iron Case-Control Studies Ferritins +2 autres

Sleeve Gastrectomy in Septuagenarians: a Case-Control Study.

09 2022

DOI: 10.1007/s11695-022-06193-8 PMID: 35788952

There are few studies published referring to bariatric surgery in patients older than 70 years. The aim of this study is to evaluate whether there are benefits to performing sleeve gastrectomy (SG) in... Data were retrospectively collected from a Private Clinic's electronic medical records of patients undergoing SG between June 2017 and September 2020. Inclusion criteria were patients older than 70 ye... Fifty patients were included in the study. Both groups were similar regarding gender, weight, BMI, and presence of DM. The 30-day morbidity and mortality were similar between the groups. The patients ... The sleeve gastrectomy surgery performed in patients over 70 years of age is safe. The early results suggest similar benefits regarding weight loss and improvement of comorbidities to those having SG ...

Aged Aged, 80 and over Case-Control Studies Gastrectomy Gastric Bypass +7 autres

Diverticulitis Familiality: A Statewide Case-Control Study.

01 11 2023

DOI: 10.1097/XCS.0000000000000799 PMID: 37403933

The etiology of diverticulitis is multifactorial and poorly understood. We estimated the familiality of diverticulitis using the Utah Population Database, a statewide database linking medical records ... We identified patients with diverticulitis diagnosed between 1998 and 2018 and age- and sex-matched controls in the Utah Population Database. Risk of diverticulitis in family members of patients and c... The study population included 9,563 diverticulitis patients (with 229,647 relatives) and 10,588 controls (with 265,693 relatives). Relatives of patients were more likely to develop diverticulitis (inc... Our results indicate that the first-, second-, and third-degree relatives of diverticulitis patients are at elevated risk of developing diverticulitis. This information may aid surgeons in counseling ...

Humans Infant Case-Control Studies Family Incidence +4 autres

Thrombocytosis in patients with spondyloarthritis: a case-control study.

15 Mar 2023

DOI: 10.1186/s12891-023-06304-1 PMID: 36922788

This study aimed to investigate the clinical and laboratory as well as radiological features of spondyloarthritis (SpA) patients with thrombocytosis and to explore risk factor for thrombocytosis in Sp... A total of 145 patients with SpA were included in this study, and non-thrombocytosis was identified in 76 patients while thrombocytosis was found in 69 patients, 38 out of the 69 patients received ant... The proportion of hip involvement (60.86% vs 36.84%, p = 0.004), bath ankylosing spondylitis disease activity index score (4.24 ± 0.55 vs 3.69 ± 0.67, p < 0.001), erythrocyte sedimentation rate (62.22... SpA patients with thrombocytosis have a higher proportion of hip involvement and disease activity compared to non-thrombocytosis SpA patients. The potential risk factors for thrombocytosis in SPA pati...

Humans Case-Control Studies Tumor Necrosis Factor Inhibitors Spondylarthritis Platelet Count +1 autres

Vestibulodynia and the Vaginal Microbiome: A Case-Control Study.

09 2022

DOI: 10.1016/j.jsxm.2022.06.014 PMID: 35871050

Recent studies of the vaginal microbiome have led to a better understanding of the microbiota and interactions with the host environment, however the role of the vaginal microbiome in vestibulodynia r... This study aims to investigate and examine differences in the bacterial and fungal microbiome among patients with vestibulodynia and healthy controls.... A case-control study was conducted examining the vaginal microbiome of 29 patients with vestibulodynia and 26 controls through Stony Brook University Obstetrics and Gynecology ambulatory clinic. Exclu... Principal component analysis (PCA) and linear discriminant analysis effect size (LefSe) were used to identify differences in relative abundance of operational taxonomic units (OTUs) for the vaginal mi... Lactobacillus species were dominant amongst both cases and controls. PCA of 16S and ITS OTUs did not show significant differences in microbiome composition between vestibulodynia patients and controls... Additional studies are needed to further assess the clinical significance of these findings.... Strengths of this study include ITS amplicon sequence analysis for fungal species diversity. Limitations of this study include small sample size and lack of racial diversity.... Our study did not find significant differences in composition or diversity between the vaginal microbiomes of cases of vestibulodynia and controls; however, the data suggests differences in abundance ...

Case-Control Studies Female Humans Microbiota Pregnancy +4 autres

Bladder cancer with pioglitazone: A case-control study.

Nov 2022

DOI: 10.1016/j.dsx.2022.102637 PMID: 36270237

Varied reports suggest a contentious relationship of bladder malignancy with pioglitazone in patients with type 2 diabetes.... To study an association (prevalence and predictors) of bladder malignancy with pioglitazone therapy in Asian-Indian type 2 diabetes patients.... In this observational multicenter study, type 2 diabetic patients attending out-patient diabetes-clinic were evaluated. A detailed history of anti-diabetic medication, dose, duration, pioglitazone usa... A total of 8000 patients were screened out of which 1560 were excluded. Among 6440 included patients, 1056 (16.3%) patients were in group A and 5384 (83.6%) group B. Patients on pioglitazone were olde... Pioglitazone use in Asian-Indians is not associated with an increased bladder cancer risk. However, pioglitazone should be restricted in individuals with history of hematuria. Age more than 58 years i...

Male Female Humans Middle Aged Pioglitazone +8 autres

Multiple Chemical Sensitivity Syndrome: First Symptoms and Evolution of the Clinical Picture: Case-Control Study/Epidemiological Case-Control Study.

29 11 2022

DOI: 10.3390/ijerph192315891 PMID: 36497963

Multiple chemical sensitivity (MCS) is a chronic condition characterized by the appearance of symptoms caused by exposure to chemical compounds that are tolerable for the general population. It mainly...

Middle Aged Humans Female Male Multiple Chemical Sensitivity +3 autres

HTRA1 methylation in peripheral blood as a potential marker for the preclinical detection of stroke: a case-control study and a prospective nested case-control study.

29 12 2022

DOI: 10.1186/s13148-022-01418-0 PMID: 36581876

Stroke is the leading cause of mortality in China. DNA methylation has essential roles in multiple diseases, but its association with stroke was barely studied. We hereby explored the association betw... The association was discovered in a hospital-based case-control study (cases/controls = 190:190) and further validated in a prospective nested case-control study including 139 cases who developed stro... In our study, altered HTRA1 methylation was associated with stroke at clinical and preclinical stages and thus may provide a potential biomarker in the blood for the risk evaluation and preclinical de...

Humans Prospective Studies Serine Endopeptidases Case-Control Studies DNA Methylation +2 autres

Dermatoses vasculaires : Questions médicales fréquentes

Termes MeSH sélectionnés :

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Sous-catégories

Angiomatose bacillaire

Maladie de Behçet

Vasculopathie livédoïde

Papulose atrophiante maligne

Maladie de Kawasaki

Polyartérite noueuse

Syndrome de Sneddon

Maladie de Takayashu

Maladie de Raynaud

Auteurs principaux

Sources (10000 au total)